Negative symptoms in patients with major depressive disorder: A preliminary report

Neuropsychiatry, Neuropsychology and Behavioral Neurology

Volumn 13, Issue 3, 2000, Pages 171-176

  Galynker, Igor I ^a,b   Cohen, Lisa J ^a   Cai, Jun ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MENTAL DISEASE; NEGATIVE SYNDROME; PRIORITY JOURNAL; PSYCHOLOGIC TEST; RATING SCALE; SCORING SYSTEM; SYMPTOM;

ADULT; AFFECT; ANTIPSYCHOTIC AGENTS; ATTENTION; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; VOLITION;

EID: 0033914724     PISSN: 0894878X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Andreasen NC. Scale for the assassment of negative symptoms (SANS). Iowa City, IA: University of Iowa, 1983.
2. Galynker I, Roane DM, Miner C, et al. Negative symptoms in patients with Alzheimer's disease. Am J Geriatr Psychiatry 1995;3: 52-9.
3. Doody RS, Massman P, Mahurin R, Law S. Positive and negative neuropsychiatric features in Alzheimer's disease. J Neuropsychol Clin Neurosci 1995;7:54-60.
4. Reichman WE, Coyne AC, Amirneni S, et al. Negative symptoms in Alzheimer's disease. Am J Psychiatry 1996;153:424-6.
5. Galynker I, Ieronimo C, Miner C, et al. Methylphenidate treatment of negative symptoms in patients with dementia. J Neuropsychiatry Clin Neurosci 1997;9:231-9.
6. Galynker I, Levinson I, Miner C, Rosenthal R. Negative symptoms in patients with basal ganglia strokes. Neuropsychiatry Neuropsychol Behav Neural 1995;8:113-7.
7. Meeks S, Gibson LL, Walker KP. "Negative symptoms," health, depression, and level of functioning among nursing home residents. Int J Geriatr Psychiatry 1992;7:203-9.
8. Branconnier R, Cole JO. The therapeutic role of methylphenidate in senile organic brain syndrome. In: Cole JO, Barrett JE, eds. Psychopathology in the aged. New York: Raven Press; 1980:183-94.
9. Kaplitz SE. Withdrawn, apathetic geriatric patients responsive to methylphenidate. J Am Geriatr Soc 1975;23:271-6.
10. Marin RS. Differential diagnosis and classification of apathy. Am J Psychiatry 1990;147:22-30.
11. Marin RS. Apathy: a neuropsychiatric syndrome. J Neuropsychol Clin Neurosci 1991;3:243-54.
12. Barrett K. Treating organic abulia with bromocriptine and lisuride: four case studies. J Neurol Neurosurg Psychiatry 1991;45:718-21.
13. Clark ANG, Mankikar GD. D-amphetamine in elderly patients refractory to rehabilitation procedures. J Am Geriatr Soc 1979;27: 174-7.
14. Galynker I, Rosenblum J, Ieronimo C, et al. Clinical significance of negative symptoms in stroke patients. Biol Psychiatry 1995;37:672 (abstract).
15. Walker-Batson D, Smith P, Curtis S, et al. Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke 1995;26:2254-9.
16. Rush AJ, Weissenburger JE. Melancholic symptom features and DSM-IV. Am J Psychiatry 1994;151:489-98.
17. Van Praag HM, Korf J, Lakke JPWF, Schut T. Dopamine metabolism in depressions, psychoses, and Parkinson's disease: the problem of the specificity of biological variables in behavior disorders. Psychol Med 1975;5:138-46.
18. Bermanzohn PC, Siris SG. Akinesia: a syndrome common to parkinsonism, retarded depression, and negative symptoms of schizophrenia. Compr Psychiatry 1992;33:221-32.
19. Pantelis C, Barues TRE, Nelson HE. Is the concept of frontal-subcortical dementia relevant to schizophrenia? Br J Psychiatry 1992;160:492-60.
20. Norman RMG, Malla AK. Correlations over time between dysphoric mood and symptomatology in schizophrenia. Compr Psychiatry 1994;35:34-8.
21. Barnes TR, Curson DA, Liddle PF, Patel M. The nature and prevalence of depression in chronic schizophrenic inpatients. Br J Psychiatry 1989;154:486-91.
22. Chaturvedi SK, Prasad Rao G, Mathai JP, et al. Negative symptoms in schizophrenia and depression. Ind J Psychiatry 1985;27:237-41.
23. Chaturvedi SK, Sarmukkaddam S. Negative symptoms as predictive factors in outcome of major depression. NIMHANS Journal 1985; 3:115-9.
24. Chaturvedi SK, Sarmukkaddam S. Do negative symptoms influence the outcome of depression? Ind J Psychiatry 1986;28:305-10.
25. Guy W. ECDEU assessment manual for psychopharmacology: publication ADM 76-338. Rockville, MD: US Department of Health. Education, and Welfare;1976:534-7.
26. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
27. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale for schizophrenia. Schizophr Bull 1987;13:261-76.
28. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading a cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
29. Lilliefors, HW. On the Kolmogorov-Smirnov test for normality with mean and variance unknown. J Am Stat Assoc 1967;64:399-402.
30. Carpenter WT, Conley RR, Buchanan RW, et al. Patient response and resource management: another view of clozapine treatment of schizophrenia. Am J Psychiatry 1995;152:827-32.
31. Harris MJ, McAdams LA, Heaton SC. Negative symptoms in late-life schizophrenia. Am J Geriatr Psychiatry 1994;2:9-20.
32. Ring N, Tantam D, Montague L, et al. Gender differences in the incidence of definite schizophrenia and atypical psychosis - focus on negative symptoms of schizophrenia. Acta Psychiatr Scand 1991; 84:489-96.
33. Kulhara P, Chadda R. A study of negative symptoms in schizophrenia and depression. Compr Psychiatry 1987;28:229-35.
34. Lewine RRJ. A discriminant validity study of negative symptoms with a special focus on depression and antipsychotic medication. Am J Psychiatry 1990;147:1463-6.
35. Goldman RS, Tandon R, Liberzon I, Greden JF. Measurement of depression and negative symptoms in schizophrenia. Psychopathology 1992;25:49-56.
36. Pogue-Geile MF, Harrow M. Negative and positive symptoms in schizophrenia and depression: a follow-up. Schizophr Bull 1984;10: 371-87.
37. Gerbaldo H, Philipp M. The deficit syndrome in schizi phrenic and nonschizophrenic patients: preliminary studies. Psychopathology 1995;28:55-63.
38. Mueser KT, Sayer SL, Schooler NR, et al. A multisite investigation of the reliability of the scale for the assessment of negative symptoms. Am J Psychiatry 1994;151:1453-62.
39. Kulhara P, Avashti A, Chadda K, et al. Negative and depressive symptomatology in schizophrenia. Br J Psychiatry 1989;154:207-11.
40. Newcomer JW, Faustman WO, Yeh W, Csernansky JG. Distinguishing depression and negative symptoms in unmedicated patients with schizophrenia. Psychiatry Res 1990;31:243-50.
41. Kibel DA, Laffont I, Liddle PF. The composition of the negative syndrome of chronic schizophrenia. Br J Psychiatry 1993;162:744-50.
42. Dollfus S, Petit M, Menard JF. Relationship between depressive and positive symptoms in schizophrenia. J Affect Disord 1993;28:61-9.
43. Dollfus S, Petit M. Principal-component analyses of PANSS and SANS-SAPS in schizophrenia: their stability in an acute phase. Eur J Psychiatry 1995;10:97-106.
44. Kirkpatrik B, Buchanan RW, Breier A, Carpenter WT, Jr. Depressive symptoms and the deficit syndrome of schizophrenia. J Nerv Ment Dis 1994;182:452-5.
45. Van Praag HM, Korf J. Retarded depression and dopamine metabolism. Psychopharmacology (Berl) 1971;19:199-203.
46. Marin RS, Firinciogullari S, Biedrzycki RC. The sources of convergence between measures of apathy and depression. J Affect Disord 1993;28:117-24.
47. Marin RS, Fogel BS, Hawkins J, et al. Apathy: a treatable syndrome. J Neuropsychol Clin Neurosci 1995;7:23-30.
48. Mendels J, Cochrane C. The nosology of depression: the endogenous-reactive concept. Am J Psychiatry 1968;124(Suppl):1-11.
49. Young MA, Scheftner WA, Klerman GL, et al. The endogenous sub-type of depression: a study of its internal construct validity. Br J Psychiatry 1986;148:257-67.
50. Klein DF. Endogenomorphic depression: a conceptual and terminological revision. Arch Gen Psychiatry 1974;31:447-54.
51. Nelson JC, Charney DS: Primary affective disorder criteria and the endogenous-reactive distinction. Arch Gen Psychiatry 1980;37:787-93.
52. Lindenmayer JP, Kay SR. Affective impairment in young acute schizophrenics: its structure, course and prognostic importance. Acta Psychiatr Scand 1987;75:287-96.
53. Goldman RS, Tapp A, Scholten R, et al. Latent structure of the Hamilton Depression Rating Scale in schizophrenia. Biol Psychol 1994;35:694 (abstract).
54. Alexopoulos GS, Abrams RC, Young RC, et al. Use of the Cornell Scale in nondemented patients. J Am Geriatr Soc 1988;36:230-6.
55. Cummings JL, Mega M, Gray K, et al. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology 1994;44:2308-14.